ERBB2 and breast cancer: This analysis showed that the ORs of HER2− breast cancer declined with increasing lifetime MET-hours of physical activity (Ptrend = 0.04), but no association was observed for breast cancers that were either moderate or strong expressers of HER2 (both Ptrend ≥ 0.76).